TARO PHARMACEUTICALS CANADA
Bharat Verma is a seasoned professional in the pharmaceutical field, currently serving as Supervisor in QC Development at Taro Pharmaceuticals Canada since January 2022. Prior roles include Senior Chemist in Development at Taro Pharmaceuticals, Analytical Scientist in Quality Method Remediation at GSK, and Specialist in Method Validation at Teva Pharmaceuticals, among others. With a rich background that includes experience as a Manager/Teacher at the Pharmaceutical Science College of Canada and various roles in analytical chemistry, Bharat has cultivated extensive expertise in quality control and method development. Educational qualifications include a Master's degree in Biochemistry and two Bachelor's degrees in Medical Laboratory Technology and Sciences, respectively. Bharat holds professional certifications as a Project Management Professional (PMP) and a Six Sigma Green Belt (CSSGB) from ASQ.
This person is not in any teams
TARO PHARMACEUTICALS CANADA
We are a global, research-driven, specialty pharmaceutical company. Established in 1950, Taro develops, manufactures and markets affordable prescription and over-the counter medications. With support from our parent company, Sun Pharma, the world's 5th largest specialty generic pharmaceutical company we are a powerful global presence. Our world class production facilities in Brampton, Ontario and nearly 600 Canadian employees give Taro Canada a uniquely Canadian perspective. Our Canadian focus on dermatology makes us a leading manufacturer and supplier of topical products such as creams, ointments, and gels. This investment in niche markets continues to differentiate Taro from our competitors. We specialize in generic prescription products, but also produce over the counter and brand name drugs. Our strong research program and niche strategy have positioned us as a central player in the specialty pharmaceutical sector.